Pharvaris N.V. PHVS
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.64M | -54.41M | -43.42M | -43.42M | -51.62M |
| Total Depreciation and Amortization | 208.50K | 122.10K | 122.90K | 122.90K | 116.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.65M | 4.44M | 5.28M | 5.28M | 13.85M |
| Change in Net Operating Assets | 7.82M | 5.67M | 2.16M | 2.16M | 3.63M |
| Cash from Operations | -43.97M | -44.18M | -35.86M | -35.86M | -34.03M |
| Capital Expenditure | -31.30K | -1.80K | -21.90K | -21.90K | 18.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -31.30K | -1.80K | -21.90K | -21.90K | 18.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -62.00K | -66.30K | -24.90K | -24.90K | -23.30K |
| Issuance of Common Stock | 113.13M | 337.30K | 171.37M | 171.37M | 400.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.19M | 500.00 | -10.91M | -10.91M | -- |
| Cash from Financing | 123.14M | 316.00K | 187.57M | 187.57M | -26.00K |
| Foreign Exchange rate Adjustments | 3.81M | 88.50K | -38.00K | -38.00K | -7.87M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.96M | -43.78M | 151.65M | 151.65M | -41.91M |